Muscle abnormalities in scleroderma

Rheumatic Disease Clinics of North America

Volumn 22, Issue 4, 1996, Pages 783-796

  Olsen, N J ^a   King Jr , L E ^a   Park, J H ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DISEASE CLASSIFICATION; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; HISTOLOGY; HUMAN; INFRARED SPECTROSCOPY; LABORATORY DIAGNOSIS; MUSCLE DISEASE; MUSCLE FATIGUE; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REVIEW; SCLERODERMA;

EID: 0029855179     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70301-X     Document Type: Article

References (45)

1. L.B. Adams J.H. Park N.J. Olsen Quantitative evaluation of improvement in muscle weakness in a scleroderma patient receiving extracorporeal photopheresis: MRI and MR spectroscopy J Am Acad Dermatol 33 1995 519 522
2. Adams-Gandhi LB, Park JH, Steward KR, et al. Near infrared spectroscopy for clinical evaluation of muscle abnormalities in dermatomyositis and scleroderma. Presented at the American Academy of Dermatology. Washington, DC, 1996.
3. L.B. Adams-Gandhi J.H. Park T.L. Vital Detection of muscle disorders in systemic scleroderma and CREST using P-31 magnetic resonance spectroscopy Arthritis Rheum 38 1995 S307
4. K. Arahata A.G. Engel Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and site of accumulation and counts of muscle fibers invaded by T cells Ann Neurol 16 1984 193 208
5. L. Averbuch-Heller I. Steiner O. Abramsky Neurologic manifestations of progressive systemic sclerosis Arch Neurol 49 1992 1292 1295
6. A. Bohan J.B. Peter Polymyositis and dermatomyositis (second of two parts) N Engl J Med 292 1975 403 407
7. A. Bohan J.B. Peter Polymyositis and dermatomyositis (first of two parts) N Engl J Med 292 1975 344 347
8. J. Bondeson A. Rausing Reversible scleroderma, fasciitis, and perimyositis Clin Exp Rheumatol 12 1994 71 73
9. A.M. Chausow T. Kane D. Levinson Reversible hypercapnic respiratory insufficiency in scleroderma caused by respiratory muscle weakness Am Rev Resp Dis 130 1984 142 144
10. P.J. Clements D.E. Furst D.S. Campion Muscle disease in progressive systemic sclerosis Arthritis Rheum 21 1978 62 71
11. L.S. DeClerck H.R. Degryse E. Wouters Magnetic resonance imaging in the evaluation of patients with eosinophilic fasciitis J Rheumatol 16 1989 1270 1273
12. F.X. DiSpaltro C. Cottrill C. Cahill Extracorporeal photochemotherapy in progressive systemic sclerosis Int J Dermatol 32 1993 417 420
13. J. Doornbos P.R. Luyten M. Janssen P-31 MR spectroscopy of skeletal and cardiac muscle metabolism in patients with systemic sclerosis: A multiple case study J Magn Reson Imaging 4 1994 165 168
14. D.J. Evans S.J. Cashman M. Walport Progressive systemic sclerosis: Autoimmune arteriopathy Lancet 1 1987 480 482
15. H.J. Finol A. Marquez H. Rivera Ultrastructure of systemic sclerosis inflammatory myopathy J Submicrosc Cytol Pathol 26 1994 245 253
16. W.P. Follansbee T.R. Zerbe T.A. Medsger Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): A high risk association Am Heart J 125 1993 194 203
17. D.D. Fraser J.A. Frank M. Dalakas Magnetic resonance imaging in the idiopathic inflammatory myopathies J Rheumatol 18 1991 1693 1699
18. P.A. Gertler R.P. Jacobs Myoadenylate deaminase deficiency in a patient with progressive systemic sclerosis Arthritis Rheum 27 1984 586 590
19. M. Giordano G. Valentini S. Migliaresi Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis J Rheumatol 13 1986 911 916
20. I. Hausmanowa-Petrusewica A. Kozminska Electromyographic findings in scleroderma Arch Neurol 4 1961 59 65
21. A. Hietaharju S. Jaaskelainen H. Kalimo Peripheral neuromuscular manifestations in systemic sclerosis (scleroderma) Muscle Nerve 16 1993 1204 1212
22. V.K. Rocco E.R. Hurd Scleroderma and scleroderma-like disorders Semin Arthritis Rheum 16 1986 22 69
23. L.E. King N.J. Olsen D. Puett Quantitative evaluation of muscle weakness in scleroderma patients using magnetic resonance imaging and spectroscopy Arch Dermatol 129 1993 246 247
24. T.A. Medsger Progressive systemic sclerosis: Skeletal muscle involvement Clin Rheum Dis 5 1979 103 113
25. T.A. Medsger G.P. Rodnan J. Moossy Skeletal muscle involvement in progressive systemic sclerosis (scleroderma) Arthritis Rheum 11 1968 554 568
26. E.D. Newman R.J. Kurland P-31 magnetic resonance spectroscopy in polymyositis and dermatomyositis: Altered energy utilization during exercise Arthritis Rheum 35 1992 199 203
27. W.L. Norton J.M. Nardo Vascular disease in progressive systemic sclerosis (scleroderma) Ann Intern Med 73 1970 317 324
28. C.V. Oddis C.H. Eisenbeis H.E. Reidbord Vasculitis in systemic sclerosis: Association with Sjogren's Syndrome and the CREST syndrome variant J Rheumatol 14 1987 942 948
29. N.J. Olsen J.H. Park Use of P-31 magnetic resonance spectroscopy and near infrared spectroscopy for serial evaluation of muscle disease Bull Rheum Dis 44 1995 4 7
30. J.H. Park L.B. Adams-Gandhi P. Phothimat Detection of muscle abnormalities in scleroderma patients using P-31 MR spectroscopy (abstract) International Soc Magnetic Resonance Medicine 14 1996 1702
31. J.H. Park D. Golwyn N.J. Olsen P-31 magnetic resonance spectroscopy and near infrared spectroscopy provide unique quantitative data for evaluation of exercising muscles Proceedings for the International Society of Optical Engineering 2275 1994 247 258
32. J.H. Park N.J. Olsen L.E. King Comparison of muscle disorders in diffuse scleroderma and CREST: Clinical applications of MRI and MRS (abstract) Soc Magnetic Resonance Medicine 10 1992 2370
33. J.H. Park N.J. Olsen L.E. King MRI and P-31 magnetic resonance spectroscopy detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis Arthritis Rheum 38 1995 68 77
34. J.H. Park J.P. VanSant N.G. Kumar Dermatomyositis: Correlative MR imaging and P-31 MR spectroscopy for quantitative evaluation of inflammatory muscle disease Radiology 177 1990 473 479
35. J.H. Park T. Vital N. Ryder MR imaging and P-31 MR spectroscopy provide unique quantitative data for longitudinal management of patients with dermatomyositis Arthritis Rheum 37 1994 736 746
36. R.A. Ringel J.E. Brick J.F. Brick Muscle involvement in the scleroderma syndromes Arch Intern Med 150 1990 2550 2552
37. A.H. Rook B. Freundlich B.V. Jegasothy Treatment of systemic sclerosis with extracorporeal photochemotherapy Arch Dermatol 128 1992 337 346
38. M.L. Russell W.M. Hanna Ultrastructure of muscle microvasculature in progressive systemic sclerosis: Relation to clinical weakness J Rheumatol 10 1983 741 747
39. M. Scarpelli R. Montironi D. Tulli Quantitative analysis of quadriceps muscle biopsy in systemic sclerosis Pathol Res Pract 188 1992 603 606
40. J.R. Seibold Scleroderma W.N. Kelley E.D. Harris S. Ruddy Textbook of Rheumatology. 1993 WB Saunders Philadelphia 1113 1143
41. J.M. Thompson R. Bluestone E.G.L. Bywaters Skeletal muscle involvement in systemic sclerosis Ann Rheum Dis 28 1969 281 288
42. D.L. Tuffanelli R.K. Winkelmann Systemic scleroderma: A clinical study of 727 cases Arch Dermatol 84 1961 49 61
43. D.L. Tuffanelli R.K. Winkelman Scleroderma and its relationship to the `collagenoses': Dermatomyositis, lupus erythematosus, rheumatoid arthritis, and Sjogren's syndrome Am J Med Sci 243 1962 133 146
44. A. Vilppula Muscular disorders in some collagen diseases Acta Med Scand 540 suppl 1972 1 47
45. S.G. West P.J. Killian O.J. Lawless Association of myositis and myocarditis in progressive systemic sclerosis Arthritis Rheum 24 1981 662 667